Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference42 articles.
1. Wildiers, H., Mauer, M., Pallis, A., Hurria, A., Mohile, S. G., Luciani, A., et al. (2013). End points and trial design in geriatric oncology research: A joint European organisation for research and treatment of cancer–Alliance for Clinical Trials in Oncology-International Society of Geriatric Oncology position article. Journal of Clinical Oncology,
31(29), 3711–3718.
https://doi.org/10.1200/jco.2013.49.6125
.
2. United States Food and Drug Administration. (2009). Patient reported outcome measures: Use in medical product development to support labelling claims. MD: US Department of Health & Human Support Food & Drug Administration.
https://www.fda.gov/downloads/drugs/guidances/ucm193282.pdf
. Accessed 23/01/2019.
3. Osoba, D. (1994). Lessons learned from measuring health-related quality of life in oncology. Journal of Clinical Oncology,
12(3), 608–616.
https://doi.org/10.1200/jco.1994.12.3.608
.
4. Revicki, D. A., Osoba, D., Fairclough, D., Barofsky, I., Berzon, R., Leidy, N. K., et al. (2000). Recommendations on health-related quality of life research to support labeling and promotional claims in the United States. Quality of Life Research,
9(8), 887–900.
5. Chen, J., Ou, L., & Hollis, S. J. (2013). A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Services Research,
13, 211.
https://doi.org/10.1186/1472-6963-13-211
.